Cargando…

Inhibition of KCTD10 Affects Diabetic Retinopathy Progression by Reducing VEGF and Affecting Angiogenesis

AIM: We purposed to evaluate the KCTD10 effects of angiogenesis in diabetic retinopathy (DR). METHODS: We induced a DR cell model using high glucose (HG) treatment of HRECs and ARPE-19 cells. A DR rat was established by injecting streptozotocin. Small interference RNA targeted KCTD10 (si-KCTD10) was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yun, Wang, Cong, Wang, Guangwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629933/ https://www.ncbi.nlm.nih.gov/pubmed/36381427 http://dx.doi.org/10.1155/2022/4112307

Ejemplares similares

Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
por: Lai, Meihua, et al.
Publicado: (2023)

EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells
por: Niu, Xuping, et al.
Publicado: (2023)

Diabetic Retinopathy and VEGF
por: Gupta, N, et al.
Publicado: (2013)

Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling
por: Long, Lingli, et al.
Publicado: (2019)

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012)

KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family
por: Liao, Yini, et al.
Publicado: (2023)

Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy
por: Chen, Dalbert J., et al.
Publicado: (2021)

Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy
por: Wang, Jiaxing, et al.
Publicado: (2014)

Apelin Affects the Progression of Osteoarthritis by Regulating VEGF-Dependent Angiogenesis and miR-150-5p Expression in Human Synovial Fibroblasts
por: Wang, Yu-Han, et al.
Publicado: (2020)

KCTD11 Tumor Suppressor Gene Expression Is Reduced in Prostate Adenocarcinoma
por: Zazzeroni, Francesca, et al.
Publicado: (2014)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
por: Bahr, Tyler A., et al.
Publicado: (2023)

KCTD20, a relative of BTBD10, is a positive regulator of Akt
por: Nawa, Mikiro, et al.
Publicado: (2013)

Association of KCTD10, MVK, and MMAB polymorphisms with dyslipidemia and coronary heart disease in Han Chinese population
por: Sun, Jie, et al.
Publicado: (2016)

The emerging role of the KCTD proteins in cancer
por: Angrisani, Annapaola, et al.
Publicado: (2021)

ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy
por: Wu, Yuexiu, et al.
Publicado: (2010)

KCTD11 inhibits progression of lung cancer by binding to β‐catenin to regulate the activity of the Wnt and Hippo pathways
por: Yang, Man, et al.
Publicado: (2021)

KCTD10 Is Involved in the Cardiovascular System and Notch Signaling during Early Embryonic Development
por: Ren, Kaiqun, et al.
Publicado: (2014)

SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression
por: Abouelnazar, Fatma A., et al.
Publicado: (2023)

Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2012)

Generation and characterization of Kctd15 mutations in zebrafish
por: Heffer, Alison, et al.
Publicado: (2017)

KCTD12 modulation of GABA(B) receptor function
por: Li, Melody, et al.
Publicado: (2017)

A Comprehensive Analysis of the Expression Profiles of KCTD Proteins in Acute Lymphoblastic Leukemia: Evidence of Selective Expression of KCTD1 in T-ALL
por: Buono, Lorena, et al.
Publicado: (2023)

Zebrafish WNK Lysine Deficient Protein Kinase 1 (wnk1) Affects Angiogenesis Associated with VEGF Signaling
por: Lai, Ju-Geng, et al.
Publicado: (2014)

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
por: Wang, Tianqin, et al.
Publicado: (2021)

Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
por: Srivastava, Suyash, et al.
Publicado: (2020)

Mitochondrial Haplogroups Affect Severity But Not Prevalence of Diabetic Retinopathy
por: Bregman, Jana A., et al.
Publicado: (2017)

FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
por: Li, Xiaoju, et al.
Publicado: (2018)

Interference with KCTD9 inhibits NK cell activation and ameliorates fulminant liver failure in mice
por: Zhang, Xiaoping, et al.
Publicado: (2018)

Tranexamic Acid Inhibits Angiogenesis and Melanogenesis in Vitro by Targeting VEGF Receptors
por: Zhu, Jian-Wei, et al.
Publicado: (2020)

Paeonol Oxime Inhibits bFGF-Induced Angiogenesis and Reduces VEGF Levels in Fibrosarcoma Cells
por: Lee, Hyo-Jeong, et al.
Publicado: (2010)

KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer
por: Yao, Hanhui, et al.
Publicado: (2022)

KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling
por: Tong, Rongliang, et al.
Publicado: (2017)

Glycation of fibronectin inhibits VEGF‐induced angiogenesis by uncoupling VEGF receptor‐2‐c‐Src crosstalk
por: Chen, Tangting, et al.
Publicado: (2020)

The BTB-Containing Protein Kctd15 Is SUMOylated In Vivo
por: Zarelli, Valeria E., et al.
Publicado: (2013)

The KCTD family of proteins: structure, function, disease relevance
por: Liu, Zhepeng, et al.
Publicado: (2013)

Contribution of KCTD12 to esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2018)

BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis
por: Huang, Chongbiao, et al.
Publicado: (2023)

к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling
por: Yamamizu, Kohei, et al.
Publicado: (2013)

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
por: Kuiper, Esther J., et al.
Publicado: (2008)

VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
por: Arrigo, Alessandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mc1bjnbigqpc0hsn54oou3s014